Chang-Hong Liang Selected Research

Chang-Hong Liang Research Topics

3	Body Weight (Weight, Body) 01/2014 - 02/2010
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2022
1	Infections 03/2021
1	Pneumonia (Pneumonitis) 03/2021
1	Neoplasms (Cancer) 07/2020
1	Fistula 01/2019
1	Aneurysm (Aneurysms) 01/2019
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019
1	Cardiomyopathies (Cardiomyopathy) 09/2017
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2017
1	Ischemia 01/2014
1	Stroke (Strokes) 01/2014
1	Cerebral Infarction 01/2014
1	Solitary Kidney 12/2010
1	Brain Neoplasms (Brain Tumor) 02/2010
1	Wounds and Injuries (Trauma) 12/2006

2	Gadolinium DTPA (Magnevist)FDA Link 01/2014 - 02/2010
2	Contrast MediaIBA 12/2010 - 02/2010
1	Biomarkers (Surrogate Marker)IBA 12/2022
1	Nucleic AcidsIBA 03/2021
1	N- (4'- fluorobutyrophenone)- 4- (4- chlorophenyl)pyridinium (HPP(+))IBA 07/2020
1	1-O-hexadecyl-2-N-methylcarbamol -sn-glycerol-3-phosphocholineIBA 01/2019
1	SmokeIBA 01/2019
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2017
1	ferumoxides (Feridex)FDA Link 01/2014
1	gadolinium ethoxybenzyl DTPA FDA Link 12/2013
1	Protons (Proton)IBA 12/2010
1	gadobenic acid (gadobenate dimeglumine)FDA Link 02/2010
1	IronIBA 12/2006

1	Catheters 01/2019
1	Therapeutics 09/2017